JUN 05, 2018 06:22 PM PDT
Mechanism of Aspirin's Anti-Colon Cancer Effects Revealed
WRITTEN BY: Carmen Leitch
2 6 485

For some people, aspirin can help prevent colon cancer; now researchers have learned more about how that happens. It seems the medicine is able to halt an important process that has been connected to the growth of tumors. The work, which was done by scientists at the University of Edinburgh, has been reported in Nucleic Acid Research. It has also revealed more about how an organelle called the nucleolus senses and responds to stress.

Colon cancer cells / Credit: Sanford Burnham Prebys Medical Discovery Institute

The investigators used tumor samples taken from colon cancer patients for part of this work. They exposed cells grown in the lab and from the patient samples to aspirin and assessed the effects. 

Their study was focused on the pathways and processes of the nucleolus, a cellular organelle where vital signaling and processes occur. The scientists found that the actions of an important molecule called TIF-1A are disrupted by aspirin. That molecule is critical for nucleoli to function. Activation of that organelle has been linked, however, to tumor formation; dysfunction in the nucleolus has been connected to Alzheimer's and Parkinson's diseases.

"We are really excited by these findings as they suggest a mechanism by which aspirin may act to prevent multiple diseases. A better understanding of how aspirin blocks TIF-IA and nucleolar activity provides great promise for the development of new treatments and targeted therapy," said Dr. Lesley Stark, of the Cancer Research UK Edinburgh Centre at the University of Edinburgh.

Long-term use of aspirin can cause internal bleeding and may result in stroke, so even though regular consumption of aspirin is known to reduce a person’s risk of developing the disease, it is not recommended. This work can help show who is most likely to benefit from the drug. Better therapeutics that have similar impacts can also be developed now.

Rates of colon cancer, also known as bowel cancer, have generally been going down. But there has been another trend; it’s on the rise in young people, and researchers don’t know why. The increase has been determined to be about three percent, and some researchers have suggested it could be due to lifestyle factors. The American Cancer Society is now recommending that people begin screening for colon cancer at age 45, instead of 50. Learn more from the video.

Sources: AAAS/Eurkekalert! Via University of Edinburgh, Journal of the National Cancer Institute, Nucleic Acids Research

About the Author
  • Experienced research scientist and technical expert...
You May Also Like
APR 25, 2018
Technology
APR 25, 2018
PCR in Under 2 Minutes: NEXTGENPCR
New thermocycler tech can amplify DNA segments in less time with less energy consumption.
APR 26, 2018
Neuroscience
APR 26, 2018
Dopamine Levels Could be a Biomarker for Alzheimer's
In the field of neuroscience, the search for information on how to diagnose, treat and perhaps even prevent Alzheimer's disease is a priority. Alzheime
MAY 02, 2018
Cell & Molecular Biology
MAY 02, 2018
Chipping Away at the Mystery of Viruses
A new method can assess how the cell's protein factory is working, leading to a better understanding of viral proteins.
MAY 30, 2018
Cell & Molecular Biology
MAY 30, 2018
Diagnosing Deadly Kidney Cancers Sooner
Researchers have found that deadly kidney cancers can be identified by assessing their evolutionary path, which is different for distinct types.
JUN 06, 2018
Cell & Molecular Biology
JUN 06, 2018
New Role for Protein Complex Provides Insight Into Cancer Development
Researchers found that RSC plays an important role in chromosome distribution.
JUN 16, 2018
Clinical & Molecular DX
JUN 16, 2018
Nanoparticles Deliver "Theranostics" for Cancer Patients
New technology combing therapeutic agents and diagnostics (theranostics) can be used to deliver drugs to cancer cells. From the Moscow Institute of Physics
Loading Comments...